Oxford BioDynamics Plc (AIM:OBD)
0.2150
-0.0100 (-4.44%)
At close: Dec 31, 2025
Oxford BioDynamics Revenue
In the fiscal year ending September 30, 2025, Oxford BioDynamics had annual revenue of 1.10M GBP with 72.17% growth. Oxford BioDynamics had revenue of 508.00K in the half year ending September 30, 2025, with 75.17% growth.
Revenue
1.10M
Revenue Growth
+72.17%
P/S Ratio
8.43
Revenue / Employee
26.71K
Employees
41
Market Cap
9.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 1.10M | 459.00K | 72.17% |
| Sep 30, 2024 | 636.00K | 126.00K | 24.71% |
| Sep 30, 2023 | 510.00K | 356.00K | 231.17% |
| Sep 30, 2022 | 154.00K | -187.00K | -54.84% |
| Sep 30, 2021 | 341.00K | -115.00K | -25.22% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
Oxford BioDynamics News
- 4 weeks ago - AIM Market Roundup: TPXImpact, Petards, RC Fornax - The Armchair Trader
- 2 months ago - AIM Market Roundup: Proteome Sciences, Greenroc Strategic Minerals, IQE - The Armchair Trader
- 2 months ago - Oxford BioDynamics has important role in future cancer screening says report - The Armchair Trader
- 3 months ago - AIM Market Roundup: WH Ireland, Bradda Head, Oxford Biodynamics - The Armchair Trader
- 6 months ago - AIM Market Roundup: Oxford Biodynamics, GCM Resources, ECO Animal Health - The Armchair Trader
- 1 year ago - AIM Market Roundup: Marechale, Oxford Biodynamics, SDX Energy - The Armchair Trader
- 1 year ago - Small Cap Stocks: i-nexus Global, Genip, Oxford Biodynamics - The Armchair Trader
- 1 year ago - Three Quick Facts: Oxford Biodynamics, Entain, Computacenter - The Armchair Trader